Company / SG&A per Share
Editas Medicine, Inc. SG&A per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.87
FY2025
5-year range
$0.86 / $1.11
FY2021-FY2025
Trend
+0.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
SG&A per Share has fluctuated over the past 8 years, ranging from $0.86 in FY2024 to $1.11 in FY2023.
Based on SEC 10-K filings.
0.87 in FY2025 with a 5-year CAGR of -3.0%.
Improved from $1.11 to $0.87 over the past 2 years.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- -4.1%
- 5-Year CAGR
- -3.0%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, sg&a per share increased 0.6% year-over-year.
- Peak sg&a per share was recorded in FY2023.
- Lowest sg&a per share in the period was in FY2024.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.48 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.87 | +0.6% |
| FY2024 | $0.86 | -21.9% |
| FY2023 | $1.11 | +12.1% |
| FY2022 | $0.99 | -4.3% |
| FY2021 | $1.03 | +2.0% |
| FY2020 | $1.01 | -2.3% |
| FY2019 | $1.04 | -0.4% |
| FY2018 | $1.04 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026